These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 11812086

  • 1. Function of the exon 7 deletion variant estrogen receptor alpha protein in an estradiol-resistant, tamoxifen-sensitive human endometrial adenocarcinoma grown in nude mice.
    Horvath G, Leser G, Helou K, Henriksson M.
    Gynecol Oncol; 2002 Feb; 84(2):271-9. PubMed ID: 11812086
    [Abstract] [Full Text] [Related]

  • 2. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
    Dardes RC, Schafer JM, Pearce ST, Osipo C, Chen B, Jordan VC.
    Gynecol Oncol; 2002 Jun; 85(3):498-506. PubMed ID: 12051881
    [Abstract] [Full Text] [Related]

  • 3. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.
    Bollig A, Miksicek RJ.
    Mol Endocrinol; 2000 May; 14(5):634-49. PubMed ID: 10809228
    [Abstract] [Full Text] [Related]

  • 4. Alternative splicing of the estrogen receptor primary transcript normally occurs in estrogen receptor positive tissues and cell lines.
    Pfeffer U, Fecarotta E, Arena G, Forlani A, Vidali G.
    J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):99-105. PubMed ID: 8603053
    [Abstract] [Full Text] [Related]

  • 5. The influence of hormones on CD44 expression in endometrial and breast carcinomas.
    Durst B, Sorg RV, Röder G, Betz B, Beckmann MW, Niederacher D, Bender HG, Dall P.
    Oncol Rep; 2001 Jan; 8(5):987-93. PubMed ID: 11496303
    [Abstract] [Full Text] [Related]

  • 6. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.
    Daffada AA, Johnston SR, Smith IE, Detre S, King N, Dowsett M.
    Cancer Res; 1995 Jan 15; 55(2):288-93. PubMed ID: 7812959
    [Abstract] [Full Text] [Related]

  • 7. Estrogen receptor mRNA splice variants in pre- and postmenopausal human endometrium and endometrial carcinoma.
    Rice LW, Jazaeri AA, Shupnik MA.
    Gynecol Oncol; 1997 Apr 15; 65(1):149-57. PubMed ID: 9103405
    [Abstract] [Full Text] [Related]

  • 8. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ, Raney S.
    Cell Biol Int; 1998 Apr 15; 22(6):413-9. PubMed ID: 10328849
    [Abstract] [Full Text] [Related]

  • 9. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
    Bhat KP, Pezzuto JM.
    Cancer Res; 2001 Aug 15; 61(16):6137-44. PubMed ID: 11507064
    [Abstract] [Full Text] [Related]

  • 10. Estrogen receptor alpha mRNA variant lacking exon 5 is co-expressed with the wild-type in endometrial adenocarcinoma.
    Cobellis L, Reis FM, Driul L, Vultaggio G, Ferretti I, Villa E, Petraglia F.
    Eur J Obstet Gynecol Reprod Biol; 2002 Apr 10; 102(1):92-5. PubMed ID: 12039098
    [Abstract] [Full Text] [Related]

  • 11. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE, Madsen MW, Briand P.
    Cancer Res; 1994 Mar 15; 54(6):1587-95. PubMed ID: 8137264
    [Abstract] [Full Text] [Related]

  • 12. Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α.
    Barone I, Brusco L, Gu G, Selever J, Beyer A, Covington KR, Tsimelzon A, Wang T, Hilsenbeck SG, Chamness GC, Andò S, Fuqua SA.
    J Natl Cancer Inst; 2011 Apr 06; 103(7):538-52. PubMed ID: 21447808
    [Abstract] [Full Text] [Related]

  • 13. Expression of estrogen receptor alpha mRNA and protein variants in human endometrial carcinoma.
    Jazaeri O, Shupnik MA, Jazaeri AA, Rice LW.
    Gynecol Oncol; 1999 Jul 06; 74(1):38-47. PubMed ID: 10385549
    [Abstract] [Full Text] [Related]

  • 14. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
    Revillion F, Pawlowski V, Lhotellier V, Louchez MM, Peyrat JP.
    Anticancer Res; 2003 Jul 06; 23(2B):1455-60. PubMed ID: 12820409
    [Abstract] [Full Text] [Related]

  • 15. Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors.
    McLeskey SW, Zhang L, El-Ashry D, Trock BJ, Lopez CA, Kharbanda S, Tobias CA, Lorant LA, Hannum RS, Dickson RB, Kern FG.
    Clin Cancer Res; 1998 Mar 06; 4(3):697-711. PubMed ID: 9533540
    [Abstract] [Full Text] [Related]

  • 16. Differential expression of estrogen receptor mRNA splice variants in the tamoxifen resistant human breast cancer cell line, MCF-7/TAMR-1 compared to the parental MCF-7 cell line.
    Madsen MW, Reiter BE, Lykkesfeldt AE.
    Mol Cell Endocrinol; 1995 Apr 01; 109(2):197-207. PubMed ID: 7664983
    [Abstract] [Full Text] [Related]

  • 17. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M, Jukić S, Ilić-Forko J, Babić D, Uzarević B, Petrovecki M, Suchanek E, Skrablin S, Dotlić S, Marusić M.
    Gynecol Oncol; 1999 Mar 01; 72(3):331-6. PubMed ID: 10053103
    [Abstract] [Full Text] [Related]

  • 18. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
    Atanaskova N, Keshamouni VG, Krueger JS, Schwartz JA, Miller F, Reddy KB.
    Oncogene; 2002 Jun 06; 21(25):4000-8. PubMed ID: 12037682
    [Abstract] [Full Text] [Related]

  • 19. A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.
    Greenberger LM, Annable T, Collins KI, Komm BS, Lyttle CR, Miller CP, Satyaswaroop PG, Zhang Y, Frost P.
    Clin Cancer Res; 2001 Oct 06; 7(10):3166-77. PubMed ID: 11595711
    [Abstract] [Full Text] [Related]

  • 20. Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene.
    Couse JF, Curtis SW, Washburn TF, Lindzey J, Golding TS, Lubahn DB, Smithies O, Korach KS.
    Mol Endocrinol; 1995 Nov 06; 9(11):1441-54. PubMed ID: 8584021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.